Avantor Performance Materials, Nusil Technology to Merge
The merger of Avantor Performance Materials and Nusil Technology positions the company for growth in bioprocessing.
Avantor Performance Materials and NuSil Technology, portfolio companies of New Mountain Capital, announced on Aug. 31, 2016 an agreement to merge. The combined company, to be named Avantor, will provide performance materials and solutions for the production and research to more than 6500 customers in the biotechnology, pharmaceutical, medical device, diagnostics, aerospace and defense, and semiconductor industries.
The combination brings complementary technologies and advanced analytical capabilities to a portfolio of mor than 30,000 products; the company reports in a press announcement that it will be positioned to support the industrialization of the biopharmaceutical sector through its bioprocessing and biomaterials offerings with a focus on productivity and quality. Combined revenues will be over $700 million, growing at 14% per year.
New Mountain is the majority owner of both companies, and will remain as the majority owner post-merger. The merger is expected to close in late September. Terms of the transaction were not disclosed.
Source: Avantor Performance Materials
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
